Glenn Vraniak

Director/Board Member at

Apollomics, Inc. (United States)

63 year

39 connections

Health Technology

Finance

Producer Manufacturing

Profile

Glenn S.
Vraniak is the founder of Perceptus.
Current job includes Independent Director at Apollomics, Inc. since 2023.
Former jobs include Independent Director at Apollomics, Inc., President at Aprecia Pharmaceuticals Co. from 2011 to 2013, Executive Vice President at GE Capital Transportation Finance from 2000 to 2002, Chief Financial Officer at Prasco LLC from 2003 to 2011, Chief Financial Officer at G&W Laboratories, Inc. from 2014 to 2016, Chief Financial & Accounting Officer at electroCore, Inc. from 2018 to 2019, Principal at Gsv Advisory Services, LLC in 2016, Chief Financial Officer at Inversago Pharma, Inc. from 2022 to 2024, CFO-Autonomous Automotive Technology Division at Valeo SE from 2021 to 2022, and Chief Financial Officer at Evaxion AS from 2019 to 2021.
Education includes undergraduate and MBA from Rutgers Center For Management Development.

Glenn Vraniak active positions

Companies	Position	Start
Apollomics, Inc. (United States) Apollomics, Inc. (United States) BiotechnologyHealth Technology Develops mono therapies and combination therapies of tumor-targeting and immuno-oncology agents	Director/Board Member	30/03/2023

All active positions of Glenn Vraniak

Former positions of Glenn Vraniak

Companies	Position	End
APOLLOMICS, INC.	Director/Board Member	03/09/2025
Inversago Pharma, Inc. Inversago Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops CB1 receptor based therapies for obesity, diabetes and complication treatment	Director of Finance/CFO	01/07/2024
VALEO SE	Corporate Officer/Principal	01/04/2022
EVAXION A/S	Director of Finance/CFO	01/10/2021
ELECTROCORE, INC.	Director of Finance/CFO	01/04/2019

See the detail of Glenn Vraniak's experience

Training of Glenn Vraniak

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Glenn Vraniak's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	13
Aprecia Pharmaceuticals Co. Aprecia Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Manufactures and develops drugs	Health Technology
Valeo SE Valeo SE Auto Parts: OEMProducer Manufacturing Manufactures and sells visibility, powertrain, thermal and driving systems	Producer Manufacturing
GE Capital Transportation Finance GE Capital Transportation Finance Finance/Rental/LeasingFinance Provides customized leases and secured loan	Finance
Prasco LLC Prasco LLC Pharmaceuticals: GenericHealth Technology Manufactures generic drugs	Health Technology
G&W Laboratories, Inc. G&W Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products	Health Technology
electroCore, Inc. electroCore, Inc. Medical SpecialtiesHealth Technology Develops non-invasive neuromodulation therapies	Health Technology
Evaxion Biotech A/S Evaxion Biotech A/S BiotechnologyHealth Technology Develops novel vaccines	Health Technology
Apollomics, Inc. (United States) Apollomics, Inc. (United States) BiotechnologyHealth Technology Develops mono therapies and combination therapies of tumor-targeting and immuno-oncology agents	Health Technology
Perceptus
Rutgers Center For Management Development Rutgers Center For Management Development Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Gsv Advisory Services, LLC
Inversago Pharma, Inc. Inversago Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops CB1 receptor based therapies for obesity, diabetes and complication treatment	Health Technology
Apollomics, Inc. Apollomics, Inc. Financial ConglomeratesFinance Operates as a biotechnology company that focuses on development of novel medicines for cancer patients	Finance